Market Closed -
Other stock markets
|
After market 01:49:15 pm | |||
109 EUR | +1.02% | 109 | +0.05% |
Jun. 04 | GERRESHEIMER AG : Jefferies remains its Buy rating | ZD |
May. 27 | Gerresheimer to Boost Production Capacity Via EUR166 Million US Expansion Project | MT |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company is in debt and has limited leeway for investment
- The firm trades with high earnings multiples: 26.19 times its 2024 earnings per share.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.53% | 4.03B | B+ | ||
-2.00% | 187B | C+ | ||
+0.51% | 110B | C | ||
-1.95% | 69.54B | A | ||
+13.68% | 46.37B | B- | ||
-6.82% | 46.05B | B- | ||
+7.97% | 42.54B | B+ | ||
+18.09% | 30.72B | B | ||
+17.70% | 25.62B | A- | ||
-7.46% | 23.32B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GXI Stock
- Ratings Gerresheimer AG